Dynamic Medical Technologies Inc.TPEX: 4138

Announcement DMT's Board of Directors of the Company approved the second quarter 2022 consolidated financial statements

· Issued by Dynamic Medical Technologies Inc.
Close
Today's Information

Provided by: DYNAMIC MEDICAL TECHNOLOGIES INC.
SEQ_NO 2 Date of announcement 2022/08/04 Time of announcement 16:18:54
Subject
 Announcement DMT's Board of Directors of the
Company approved the second quarter 2022 consolidated
financial statements
Date of events 2022/08/04 To which item it meets paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/04
2.Date of the audit committee approved:2022/08/04
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):587,686
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):224,676
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):87,007
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):94,530
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):72,671
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):72,072
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):2.40
11.Total assets end of the period (thousand NTD):2,495,769
12.Total liabilities end of the period
(thousand NTD):1,055,156
13.Equity attributable to owners of parent end of the
period (thousand NTD):1,265,073
14.Any other matters that need to be specified:NA

Company analysis

Earlier from Dynamic Medical Technologies

All Dynamic Medical Technologies news releases